AI-powered, personalised ‘digital drugs’ are a reality now in health interventions.
SUNIL KUMAR, (name changed), a middle-aged IT professional from suburban Mumbai, found that he had high levels of blood sugar and symptoms of Type II diabetes after a routine blood test. The diabetologist prescribed a few medicines. But the last one jotted down after obtaining Kumar’s consent, took him by surprise. It was a mobile app called Wellthy Care.
The next day he got a call from Wellthy Therapeutics and soon, a kit with a blood glucose monitoring equipment and an ‘activation card’ was home-delivered. Since then, Wellthy is monitoring Kumar’s movements via his smartphone. If he orders a pizza from his mobile app or books a weekend movie ticket using his smartphone, he starts getting alerts on last week’s sugar levels and tips via chat on advisable food for the day and the week ahead. At times, the alert goes to his wife, Suma, advising her to include more salads and vegetables in Kumar’s lunchbox.
That is not all. If Kumar’s smartphone does not record any movement for hours, Carey, the personal health coach on the app, says, “Why don’t you talk to your client while walking to and fro to burn a few calories?” Despite being under constant surveillance, Kumar is happy. So are his family and his doctor. His food habits and health are going the way they want, and his sugar levels are under control.
Welcome to an all-new world of personalised, digital health care as Mumbai-based Wellthy Therapeutics claims to be India’s (and possibly South Asia’s) first and only ‘prescription digital therapeutics’ company.
What Is Digital Therapeutics
هذه القصة مأخوذة من طبعة August 12, 2018 من Business Today.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.
بالفعل مشترك ? تسجيل الدخول
هذه القصة مأخوذة من طبعة August 12, 2018 من Business Today.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.
بالفعل مشترك? تسجيل الدخول
"Focus on the challenge of each customer"
SHASHANK KUMAR MD & CO-FOUNDER I RAZORPAY Razorpay is India's first full-stack financial solutions company
PEDAL ON THE FUTURE
THE MG WINDSOR EV, WITH ITS FUTURISTIC AND MINIMALIST DESIGN, COMBINES THE BEST OF BOTH WORLDS-COMFORT AND TECHNOLOGY
BREATHE EASY
Whether you're battling allergies, looking to remove pollutants, or simply want to breathe easier, the right air purifier can make a difference
The Taste of India in a Glass
FROM ROYAL LIQUEURS TO DISTILLED MAHUA, INDIAN HERITAGE ALCOHOLIC BEVERAGES ARE HAVING THEIR DAY IN THE SUN
LOOK BEFORE YOU LEAP
IN 2025, INVESTORS WILL NEED TO FACTOR IN VOLATILITY ACROSS ASSET CLASSES
MISSING ADVISORS
INDIA HAS JUST ONE INVESTMENT ADVISOR FOR NEARLY EVERY 200,000 INVESTORS. AT A TIME WHEN RETAIL PARTICIPATION IN THE STOCK MARKETS IS BOOMING, THIS ASSUMES SIGNIFICANCE
TURNING A CORNER
SHARED ELECTRIC MOBILITY START-UP YULU'S SHIFT TO SERVICING THE QUICK COMMERCE SECTOR IS HELPING IT GROW FAST. IT IS NOW FOCUSSING ON IMPROVING ROAD SAFETY FEATURES AS IT TURNS EBITDA POSITIVE
REALITY CHECK
INDIAN STOCK MARKETS PLUNGED BEGINNING OCTOBER FOR A HOST OF REASONS, INCLUDING A FALL IN FII OWNERSHIP. HOW DEEP WILL THE CORRECTION BE?
TRUMP'S TRADE TANGO
The return of Donald Trump as the 47th President of the US has put the global economy on edge. India, too, is unlikely to remain unaffected. How will policymakers meet this latest challenge?
"The essence of the Trump administration will be transactional”
Global investor, analyst, and best-selling author Ruchir Sharma decodes why Donald Trump won the elections, what India should do, the risks, and more
